Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B

The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk...

Descripción completa

Detalles Bibliográficos
Autores principales: Fay, Vanessa da Silva, Rodrigues, Diana Mara Garcia, Gonçalves, Stela Maris Bottin, Gregianini, Tatiana Schaffer, Bonamigo, Renan Rangel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2018
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001099/
https://www.ncbi.nlm.nih.gov/pubmed/29924220
http://dx.doi.org/10.1590/abd1806-4841.20187364
_version_ 1783331914587832320
author Fay, Vanessa da Silva
Rodrigues, Diana Mara Garcia
Gonçalves, Stela Maris Bottin
Gregianini, Tatiana Schaffer
Bonamigo, Renan Rangel
author_facet Fay, Vanessa da Silva
Rodrigues, Diana Mara Garcia
Gonçalves, Stela Maris Bottin
Gregianini, Tatiana Schaffer
Bonamigo, Renan Rangel
author_sort Fay, Vanessa da Silva
collection PubMed
description The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were evaluated in IPB-LACEN/RS and 13 (15.8%) were resistant: 10/52 were from superficial mycoses and 3/30 from systemic mycoses. The data from the study point to the need for permanent vigilance regarding the careful evaluation in the prescription and clinical and laboratory follow-up of patients affected by fungal infections.
format Online
Article
Text
id pubmed-6001099
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-60010992018-06-19 Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B Fay, Vanessa da Silva Rodrigues, Diana Mara Garcia Gonçalves, Stela Maris Bottin Gregianini, Tatiana Schaffer Bonamigo, Renan Rangel An Bras Dermatol Communication The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were evaluated in IPB-LACEN/RS and 13 (15.8%) were resistant: 10/52 were from superficial mycoses and 3/30 from systemic mycoses. The data from the study point to the need for permanent vigilance regarding the careful evaluation in the prescription and clinical and laboratory follow-up of patients affected by fungal infections. Sociedade Brasileira de Dermatologia 2018 /pmc/articles/PMC6001099/ /pubmed/29924220 http://dx.doi.org/10.1590/abd1806-4841.20187364 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way.
spellingShingle Communication
Fay, Vanessa da Silva
Rodrigues, Diana Mara Garcia
Gonçalves, Stela Maris Bottin
Gregianini, Tatiana Schaffer
Bonamigo, Renan Rangel
Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
title Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
title_full Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
title_fullStr Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
title_full_unstemmed Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
title_short Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
title_sort drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin b
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001099/
https://www.ncbi.nlm.nih.gov/pubmed/29924220
http://dx.doi.org/10.1590/abd1806-4841.20187364
work_keys_str_mv AT fayvanessadasilva drugsusceptibilityinemergingfungalinfectionstestswithfluconazoleitraconazoleandamphotericinb
AT rodriguesdianamaragarcia drugsusceptibilityinemergingfungalinfectionstestswithfluconazoleitraconazoleandamphotericinb
AT goncalvesstelamarisbottin drugsusceptibilityinemergingfungalinfectionstestswithfluconazoleitraconazoleandamphotericinb
AT gregianinitatianaschaffer drugsusceptibilityinemergingfungalinfectionstestswithfluconazoleitraconazoleandamphotericinb
AT bonamigorenanrangel drugsusceptibilityinemergingfungalinfectionstestswithfluconazoleitraconazoleandamphotericinb

Ejemplares similares